1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cell Detection Instrument Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Circulating Tumor Cell Detection Instrument by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Circulating Tumor Cell Detection Instrument by Country/Region, 2018, 2022 & 2029
2.2 Circulating Tumor Cell Detection Instrument Segment by Type
2.2.1 RNA-based Techniques
2.2.2 Microfluidic Chips-based Techniques
2.2.3 Immunostaining and Immunofluorescence Labeling-based Techniques
2.2.4 Other
2.3 Circulating Tumor Cell Detection Instrument Sales by Type
2.3.1 Global Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
2.3.2 Global Circulating Tumor Cell Detection Instrument Revenue and Market Share by Type (2018-2023)
2.3.3 Global Circulating Tumor Cell Detection Instrument Sale Price by Type (2018-2023)
2.4 Circulating Tumor Cell Detection Instrument Segment by Application
2.4.1 Drug R&D Institutions and Laboratories
2.4.2 Hospital
2.4.3 Other
2.5 Circulating Tumor Cell Detection Instrument Sales by Application
2.5.1 Global Circulating Tumor Cell Detection Instrument Sale Market Share by Application (2018-2023)
2.5.2 Global Circulating Tumor Cell Detection Instrument Revenue and Market Share by Application (2018-2023)
2.5.3 Global Circulating Tumor Cell Detection Instrument Sale Price by Application (2018-2023)
3 Global Circulating Tumor Cell Detection Instrument by Company
3.1 Global Circulating Tumor Cell Detection Instrument Breakdown Data by Company
3.1.1 Global Circulating Tumor Cell Detection Instrument Annual Sales by Company (2018-2023)
3.1.2 Global Circulating Tumor Cell Detection Instrument Sales Market Share by Company (2018-2023)
3.2 Global Circulating Tumor Cell Detection Instrument Annual Revenue by Company (2018-2023)
3.2.1 Global Circulating Tumor Cell Detection Instrument Revenue by Company (2018-2023)
3.2.2 Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Company (2018-2023)
3.3 Global Circulating Tumor Cell Detection Instrument Sale Price by Company
3.4 Key Manufacturers Circulating Tumor Cell Detection Instrument Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circulating Tumor Cell Detection Instrument Product Location Distribution
3.4.2 Players Circulating Tumor Cell Detection Instrument Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Circulating Tumor Cell Detection Instrument by Geographic Region
4.1 World Historic Circulating Tumor Cell Detection Instrument Market Size by Geographic Region (2018-2023)
4.1.1 Global Circulating Tumor Cell Detection Instrument Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Circulating Tumor Cell Detection Instrument Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Circulating Tumor Cell Detection Instrument Market Size by Country/Region (2018-2023)
4.2.1 Global Circulating Tumor Cell Detection Instrument Annual Sales by Country/Region (2018-2023)
4.2.2 Global Circulating Tumor Cell Detection Instrument Annual Revenue by Country/Region (2018-2023)
4.3 Americas Circulating Tumor Cell Detection Instrument Sales Growth
4.4 APAC Circulating Tumor Cell Detection Instrument Sales Growth
4.5 Europe Circulating Tumor Cell Detection Instrument Sales Growth
4.6 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Growth
5 Americas
5.1 Americas Circulating Tumor Cell Detection Instrument Sales by Country
5.1.1 Americas Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023)
5.1.2 Americas Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023)
5.2 Americas Circulating Tumor Cell Detection Instrument Sales by Type
5.3 Americas Circulating Tumor Cell Detection Instrument Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cell Detection Instrument Sales by Region
6.1.1 APAC Circulating Tumor Cell Detection Instrument Sales by Region (2018-2023)
6.1.2 APAC Circulating Tumor Cell Detection Instrument Revenue by Region (2018-2023)
6.2 APAC Circulating Tumor Cell Detection Instrument Sales by Type
6.3 APAC Circulating Tumor Cell Detection Instrument Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Circulating Tumor Cell Detection Instrument by Country
7.1.1 Europe Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023)
7.1.2 Europe Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023)
7.2 Europe Circulating Tumor Cell Detection Instrument Sales by Type
7.3 Europe Circulating Tumor Cell Detection Instrument Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cell Detection Instrument by Country
8.1.1 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023)
8.1.2 Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023)
8.2 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Type
8.3 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell Detection Instrument
10.3 Manufacturing Process Analysis of Circulating Tumor Cell Detection Instrument
10.4 Industry Chain Structure of Circulating Tumor Cell Detection Instrument
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circulating Tumor Cell Detection Instrument Distributors
11.3 Circulating Tumor Cell Detection Instrument Customer
12 World Forecast Review for Circulating Tumor Cell Detection Instrument by Geographic Region
12.1 Global Circulating Tumor Cell Detection Instrument Market Size Forecast by Region
12.1.1 Global Circulating Tumor Cell Detection Instrument Forecast by Region (2024-2029)
12.1.2 Global Circulating Tumor Cell Detection Instrument Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Circulating Tumor Cell Detection Instrument Forecast by Type
12.7 Global Circulating Tumor Cell Detection Instrument Forecast by Application
13 Key Players Analysis
13.1 Menarini-Silicon Biosystemsc
13.1.1 Menarini-Silicon Biosystemsc Company Information
13.1.2 Menarini-Silicon Biosystemsc Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.1.3 Menarini-Silicon Biosystemsc Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Menarini-Silicon Biosystemsc Main Business Overview
13.1.5 Menarini-Silicon Biosystemsc Latest Developments
13.2 ApoStream
13.2.1 ApoStream Company Information
13.2.2 ApoStream Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.2.3 ApoStream Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ApoStream Main Business Overview
13.2.5 ApoStream Latest Developments
13.3 Epic Sciences
13.3.1 Epic Sciences Company Information
13.3.2 Epic Sciences Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.3.3 Epic Sciences Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Epic Sciences Main Business Overview
13.3.5 Epic Sciences Latest Developments
13.4 CapitalBio Technology
13.4.1 CapitalBio Technology Company Information
13.4.2 CapitalBio Technology Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.4.3 CapitalBio Technology Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CapitalBio Technology Main Business Overview
13.4.5 CapitalBio Technology Latest Developments
13.5 Surexam Bio-Tech
13.5.1 Surexam Bio-Tech Company Information
13.5.2 Surexam Bio-Tech Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.5.3 Surexam Bio-Tech Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Surexam Bio-Tech Main Business Overview
13.5.5 Surexam Bio-Tech Latest Developments
13.6 Fluxion Biosciences
13.6.1 Fluxion Biosciences Company Information
13.6.2 Fluxion Biosciences Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.6.3 Fluxion Biosciences Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fluxion Biosciences Main Business Overview
13.6.5 Fluxion Biosciences Latest Developments
13.7 Ikonisys
13.7.1 Ikonisys Company Information
13.7.2 Ikonisys Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.7.3 Ikonisys Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ikonisys Main Business Overview
13.7.5 Ikonisys Latest Developments
13.8 Hangzhou Watson Biotech
13.8.1 Hangzhou Watson Biotech Company Information
13.8.2 Hangzhou Watson Biotech Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.8.3 Hangzhou Watson Biotech Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hangzhou Watson Biotech Main Business Overview
13.8.5 Hangzhou Watson Biotech Latest Developments
13.9 Biocept
13.9.1 Biocept Company Information
13.9.2 Biocept Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.9.3 Biocept Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biocept Main Business Overview
13.9.5 Biocept Latest Developments
13.10 ANGLE
13.10.1 ANGLE Company Information
13.10.2 ANGLE Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.10.3 ANGLE Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ANGLE Main Business Overview
13.10.5 ANGLE Latest Developments
13.11 MicroDiag Biomedicine
13.11.1 MicroDiag Biomedicine Company Information
13.11.2 MicroDiag Biomedicine Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.11.3 MicroDiag Biomedicine Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MicroDiag Biomedicine Main Business Overview
13.11.5 MicroDiag Biomedicine Latest Developments
13.12 Cellomics
13.12.1 Cellomics Company Information
13.12.2 Cellomics Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.12.3 Cellomics Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Cellomics Main Business Overview
13.12.5 Cellomics Latest Developments
13.13 ZHIHUI MEDICAL
13.13.1 ZHIHUI MEDICAL Company Information
13.13.2 ZHIHUI MEDICAL Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.13.3 ZHIHUI MEDICAL Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 ZHIHUI MEDICAL Main Business Overview
13.13.5 ZHIHUI MEDICAL Latest Developments
13.14 ZIGZAG Biotechnology
13.14.1 ZIGZAG Biotechnology Company Information
13.14.2 ZIGZAG Biotechnology Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.14.3 ZIGZAG Biotechnology Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ZIGZAG Biotechnology Main Business Overview
13.14.5 ZIGZAG Biotechnology Latest Developments
13.15 PDT
13.15.1 PDT Company Information
13.15.2 PDT Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
13.15.3 PDT Circulating Tumor Cell Detection Instrument Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 PDT Main Business Overview
13.15.5 PDT Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Circulating Tumor Cell Detection Instrument Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Circulating Tumor Cell Detection Instrument Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of RNA-based Techniques
Table 4. Major Players of Microfluidic Chips-based Techniques
Table 5. Major Players of Immunostaining and Immunofluorescence Labeling-based Techniques
Table 6. Major Players of Other
Table 7. Global Circulating Tumor Cell Detection Instrument Sales by Type (2018-2023) & (K Units)
Table 8. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
Table 9. Global Circulating Tumor Cell Detection Instrument Revenue by Type (2018-2023) & ($ million)
Table 10. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Type (2018-2023)
Table 11. Global Circulating Tumor Cell Detection Instrument Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Circulating Tumor Cell Detection Instrument Sales by Application (2018-2023) & (K Units)
Table 13. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2018-2023)
Table 14. Global Circulating Tumor Cell Detection Instrument Revenue by Application (2018-2023)
Table 15. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Application (2018-2023)
Table 16. Global Circulating Tumor Cell Detection Instrument Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Circulating Tumor Cell Detection Instrument Sales by Company (2018-2023) & (K Units)
Table 18. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Company (2018-2023)
Table 19. Global Circulating Tumor Cell Detection Instrument Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Company (2018-2023)
Table 21. Global Circulating Tumor Cell Detection Instrument Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Circulating Tumor Cell Detection Instrument Producing Area Distribution and Sales Area
Table 23. Players Circulating Tumor Cell Detection Instrument Products Offered
Table 24. Circulating Tumor Cell Detection Instrument Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Circulating Tumor Cell Detection Instrument Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Circulating Tumor Cell Detection Instrument Sales Market Share Geographic Region (2018-2023)
Table 29. Global Circulating Tumor Cell Detection Instrument Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Circulating Tumor Cell Detection Instrument Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Country/Region (2018-2023)
Table 33. Global Circulating Tumor Cell Detection Instrument Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023) & (K Units)
Table 36. Americas Circulating Tumor Cell Detection Instrument Sales Market Share by Country (2018-2023)
Table 37. Americas Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Circulating Tumor Cell Detection Instrument Revenue Market Share by Country (2018-2023)
Table 39. Americas Circulating Tumor Cell Detection Instrument Sales by Type (2018-2023) & (K Units)
Table 40. Americas Circulating Tumor Cell Detection Instrument Sales by Application (2018-2023) & (K Units)
Table 41. APAC Circulating Tumor Cell Detection Instrument Sales by Region (2018-2023) & (K Units)
Table 42. APAC Circulating Tumor Cell Detection Instrument Sales Market Share by Region (2018-2023)
Table 43. APAC Circulating Tumor Cell Detection Instrument Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Circulating Tumor Cell Detection Instrument Revenue Market Share by Region (2018-2023)
Table 45. APAC Circulating Tumor Cell Detection Instrument Sales by Type (2018-2023) & (K Units)
Table 46. APAC Circulating Tumor Cell Detection Instrument Sales by Application (2018-2023) & (K Units)
Table 47. Europe Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023) & (K Units)
Table 48. Europe Circulating Tumor Cell Detection Instrument Sales Market Share by Country (2018-2023)
Table 49. Europe Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Circulating Tumor Cell Detection Instrument Revenue Market Share by Country (2018-2023)
Table 51. Europe Circulating Tumor Cell Detection Instrument Sales by Type (2018-2023) & (K Units)
Table 52. Europe Circulating Tumor Cell Detection Instrument Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Circulating Tumor Cell Detection Instrument
Table 60. Key Market Challenges & Risks of Circulating Tumor Cell Detection Instrument
Table 61. Key Industry Trends of Circulating Tumor Cell Detection Instrument
Table 62. Circulating Tumor Cell Detection Instrument Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Circulating Tumor Cell Detection Instrument Distributors List
Table 65. Circulating Tumor Cell Detection Instrument Customer List
Table 66. Global Circulating Tumor Cell Detection Instrument Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Circulating Tumor Cell Detection Instrument Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Circulating Tumor Cell Detection Instrument Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Circulating Tumor Cell Detection Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Circulating Tumor Cell Detection Instrument Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Circulating Tumor Cell Detection Instrument Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Circulating Tumor Cell Detection Instrument Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Circulating Tumor Cell Detection Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Circulating Tumor Cell Detection Instrument Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Circulating Tumor Cell Detection Instrument Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Circulating Tumor Cell Detection Instrument Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Circulating Tumor Cell Detection Instrument Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Menarini-Silicon Biosystemsc Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 81. Menarini-Silicon Biosystemsc Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 82. Menarini-Silicon Biosystemsc Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Menarini-Silicon Biosystemsc Main Business
Table 84. Menarini-Silicon Biosystemsc Latest Developments
Table 85. ApoStream Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 86. ApoStream Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 87. ApoStream Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. ApoStream Main Business
Table 89. ApoStream Latest Developments
Table 90. Epic Sciences Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 91. Epic Sciences Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 92. Epic Sciences Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Epic Sciences Main Business
Table 94. Epic Sciences Latest Developments
Table 95. CapitalBio Technology Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 96. CapitalBio Technology Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 97. CapitalBio Technology Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CapitalBio Technology Main Business
Table 99. CapitalBio Technology Latest Developments
Table 100. Surexam Bio-Tech Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 101. Surexam Bio-Tech Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 102. Surexam Bio-Tech Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Surexam Bio-Tech Main Business
Table 104. Surexam Bio-Tech Latest Developments
Table 105. Fluxion Biosciences Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 106. Fluxion Biosciences Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 107. Fluxion Biosciences Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Fluxion Biosciences Main Business
Table 109. Fluxion Biosciences Latest Developments
Table 110. Ikonisys Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 111. Ikonisys Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 112. Ikonisys Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ikonisys Main Business
Table 114. Ikonisys Latest Developments
Table 115. Hangzhou Watson Biotech Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 116. Hangzhou Watson Biotech Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 117. Hangzhou Watson Biotech Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Hangzhou Watson Biotech Main Business
Table 119. Hangzhou Watson Biotech Latest Developments
Table 120. Biocept Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 121. Biocept Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 122. Biocept Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Biocept Main Business
Table 124. Biocept Latest Developments
Table 125. ANGLE Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 126. ANGLE Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 127. ANGLE Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. ANGLE Main Business
Table 129. ANGLE Latest Developments
Table 130. MicroDiag Biomedicine Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 131. MicroDiag Biomedicine Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 132. MicroDiag Biomedicine Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. MicroDiag Biomedicine Main Business
Table 134. MicroDiag Biomedicine Latest Developments
Table 135. Cellomics Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 136. Cellomics Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 137. Cellomics Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Cellomics Main Business
Table 139. Cellomics Latest Developments
Table 140. ZHIHUI MEDICAL Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 141. ZHIHUI MEDICAL Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 142. ZHIHUI MEDICAL Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. ZHIHUI MEDICAL Main Business
Table 144. ZHIHUI MEDICAL Latest Developments
Table 145. ZIGZAG Biotechnology Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 146. ZIGZAG Biotechnology Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 147. ZIGZAG Biotechnology Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. ZIGZAG Biotechnology Main Business
Table 149. ZIGZAG Biotechnology Latest Developments
Table 150. PDT Basic Information, Circulating Tumor Cell Detection Instrument Manufacturing Base, Sales Area and Its Competitors
Table 151. PDT Circulating Tumor Cell Detection Instrument Product Portfolios and Specifications
Table 152. PDT Circulating Tumor Cell Detection Instrument Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. PDT Main Business
Table 154. PDT Latest Developments
List of Figures
Figure 1. Picture of Circulating Tumor Cell Detection Instrument
Figure 2. Circulating Tumor Cell Detection Instrument Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circulating Tumor Cell Detection Instrument Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Circulating Tumor Cell Detection Instrument Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Circulating Tumor Cell Detection Instrument Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of RNA-based Techniques
Figure 10. Product Picture of Microfluidic Chips-based Techniques
Figure 11. Product Picture of Immunostaining and Immunofluorescence Labeling-based Techniques
Figure 12. Product Picture of Other
Figure 13. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Type in 2022
Figure 14. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Type (2018-2023)
Figure 15. Circulating Tumor Cell Detection Instrument Consumed in Drug R&D Institutions and Laboratories
Figure 16. Global Circulating Tumor Cell Detection Instrument Market: Drug R&D Institutions and Laboratories (2018-2023) & (K Units)
Figure 17. Circulating Tumor Cell Detection Instrument Consumed in Hospital
Figure 18. Global Circulating Tumor Cell Detection Instrument Market: Hospital (2018-2023) & (K Units)
Figure 19. Circulating Tumor Cell Detection Instrument Consumed in Other
Figure 20. Global Circulating Tumor Cell Detection Instrument Market: Other (2018-2023) & (K Units)
Figure 21. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2022)
Figure 22. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Application in 2022
Figure 23. Circulating Tumor Cell Detection Instrument Sales Market by Company in 2022 (K Units)
Figure 24. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Company in 2022
Figure 25. Circulating Tumor Cell Detection Instrument Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Company in 2022
Figure 27. Global Circulating Tumor Cell Detection Instrument Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Circulating Tumor Cell Detection Instrument Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Circulating Tumor Cell Detection Instrument Sales 2018-2023 (K Units)
Figure 30. Americas Circulating Tumor Cell Detection Instrument Revenue 2018-2023 ($ Millions)
Figure 31. APAC Circulating Tumor Cell Detection Instrument Sales 2018-2023 (K Units)
Figure 32. APAC Circulating Tumor Cell Detection Instrument Revenue 2018-2023 ($ Millions)
Figure 33. Europe Circulating Tumor Cell Detection Instrument Sales 2018-2023 (K Units)
Figure 34. Europe Circulating Tumor Cell Detection Instrument Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue 2018-2023 ($ Millions)
Figure 37. Americas Circulating Tumor Cell Detection Instrument Sales Market Share by Country in 2022
Figure 38. Americas Circulating Tumor Cell Detection Instrument Revenue Market Share by Country in 2022
Figure 39. Americas Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
Figure 40. Americas Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2018-2023)
Figure 41. United States Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Circulating Tumor Cell Detection Instrument Sales Market Share by Region in 2022
Figure 46. APAC Circulating Tumor Cell Detection Instrument Revenue Market Share by Regions in 2022
Figure 47. APAC Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
Figure 48. APAC Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2018-2023)
Figure 49. China Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Circulating Tumor Cell Detection Instrument Sales Market Share by Country in 2022
Figure 57. Europe Circulating Tumor Cell Detection Instrument Revenue Market Share by Country in 2022
Figure 58. Europe Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
Figure 59. Europe Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2018-2023)
Figure 60. Germany Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Circulating Tumor Cell Detection Instrument Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Market Share by Application (2018-2023)
Figure 69. Egypt Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Circulating Tumor Cell Detection Instrument Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Circulating Tumor Cell Detection Instrument in 2022
Figure 75. Manufacturing Process Analysis of Circulating Tumor Cell Detection Instrument
Figure 76. Industry Chain Structure of Circulating Tumor Cell Detection Instrument
Figure 77. Channels of Distribution
Figure 78. Global Circulating Tumor Cell Detection Instrument Sales Market Forecast by Region (2024-2029)
Figure 79. Global Circulating Tumor Cell Detection Instrument Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Circulating Tumor Cell Detection Instrument Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Circulating Tumor Cell Detection Instrument Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Circulating Tumor Cell Detection Instrument Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Circulating Tumor Cell Detection Instrument Revenue Market Share Forecast by Application (2024-2029)

※参考情報 循環腫瘍細胞検出装置は、がん治療の進展とともに重要性を増している医療機器です。この装置は、血液中に存在する循環腫瘍細胞（CTC）を特定し、分離するために使用されます。CTCは腫瘍から放出される細胞であり、がんの進行や転移の指標として注目されています。以下に、この装置の概念や特徴、種類、用途、関連技術について説明します。 まず、循環腫瘍細胞の定義ですが、CTCとは、がん細胞が腫瘍の局所から血流に入って成体の血中を循環している細胞を指します。CTCはがんの転移過程において極めて重要であり、その数や特性を調べることで、がんの進行状況や治療効果、再発のリスクを評価することが可能です。このため、CTCを検出・解析することは、がんの早期診断や治療戦略の立案において重要な役割を果たします。 循環腫瘍細胞検出装置にはいくつかの特徴があります。まず第一に、微量な血液サンプルを用いてCTCを検出できる点です。これにより、患者に対する負担が軽減されるとともに、連続的な治療効果のモニタリングが可能になります。次に、直感的な操作性が求められ、医療現場での迅速な結果提供が可能であることも重要です。また、検出精度が高く、他の細胞と区別するための高い選択性を持つことが求められます。さらに、CTCの解析だけでなく、細胞の分離や培養、さらには遺伝子解析などの機能を統合した複合的な装置も増えてきています。 循環腫瘍細胞検出装置にはいくつかの種類があります。一般的な方式としては、フィルタリング法、セルセレクション法、マイクロ流体技術などが挙げられます。フィルタリング法は、血液をフィルターに通過させることでCTCを捕捉する方法です。この方式は技術的に比較的簡単で、大量のサンプルを処理するのに適しています。セルセレクション法では、抗体を用いて特異的にCTCを捕まえる技術が使われます。この方法は、高感度で特異的な検出が可能ですが、処理が複雑になることがあります。 マイクロ流体技術は、微細な流体デバイスを用いてCTCを分離する高度な技術です。この技術では、流体の挙動や細胞の特性を利用して、非常に効率的にCTCを捕らえることができます。また、音波や電気的な力を用いる技術も登場しており、これによりさらなる精緻な操作が可能になっています。 CTC検出装置は様々な用途があります。まず、がんの早期診断や定期的なモニタリングのために使用されます。血液検査でCTCの数や特性を調べることで、がんの進行状況を把握でき、適切な治療法を選択するための重要な情報を提供します。また、治療効果の評価にも用いられ、化学療法や放射線療法に対する反応を確認するための指標として機能します。さらに、再発リスクの評価や、個別化医療の情報を得るためのツールとしても重宝されています。近年では、がんの種類によって異なるCTCの特性を解析し、パーソナライズドメディスンの基盤を築く試みも進められています。 関連技術としては、次世代シーケンシング（NGS）や高解像度顕微鏡技術などが挙げられます。NGSはCTCの遺伝子変異を解析するために利用され、がんの進行に関わる遺伝子の変化を詳細に調査することができます。また、高解像度顕微鏡はCTCの形態や表面マーカーを詳細に観察するためのツールであり、がん細胞の特性を理解するために重要です。これらの技術とCTC検出装置の組み合わせにより、がん研究はより進化した方向へと進んでいます。 循環腫瘍細胞検出装置の展望について考えると、今後さらに高精度で迅速な検出が可能となり、臨床現場での利用が拡大すると期待されます。また、AI技術を活用したデータ解析システムの導入によって、大量のCTCデータを効率的に処理できるようになれば、今までにはなかった新たな知見を得ることが可能になるでしょう。これにより、患者ごとに適した治療法を選択するためのパーソナライズドメディスンは、より実現可能になると考えられます。 循環腫瘍細胞検出装置は、がん研究・治療の最前線で欠かせない存在となっており、今後もその発展が期待されています。この装置を通じて、患者に対するより良い医療の提供や、がん治療の進化に繋がることが求められています。医療技術が進歩する中で、多様な技術やアプローチが融合し、新たな治療戦略を検討するための重要な道筋を照らすことになるでしょう。以上のように、循環腫瘍細胞検出装置は、現代のがん医療に欠かせないツールであり、今後の革新に期待が寄せられています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer